Nanjing Red Sun Co.,Ltd.

SZSE:000525 Rapporto sulle azioni

Cap. di mercato: CN¥5.7b

Nanjing Red SunLtd Performance dei guadagni passati

Il passato criteri di controllo 0/6

Nanjing Red SunLtd's earnings have been declining at an average annual rate of -1.4%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 2.7% per year.

Informazioni chiave

-1.4%

Tasso di crescita degli utili

-1.5%

Tasso di crescita dell'EPS

Chemicals Crescita del settore12.1%
Tasso di crescita dei ricavi-2.7%
Rendimento del capitale proprio-37.0%
Margine netto-11.8%
Ultimo aggiornamento sui guadagni30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Nanjing Red Sun Co.,Ltd. (SZSE:000525) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

Aug 22
Nanjing Red Sun Co.,Ltd. (SZSE:000525) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

Is Nanjing Red SunLtd (SZSE:000525) A Risky Investment?

Aug 09
Is Nanjing Red SunLtd (SZSE:000525) A Risky Investment?

Why Investors Shouldn't Be Surprised By Nanjing Red Sun Co.,Ltd.'s (SZSE:000525) 25% Share Price Plunge

May 13
Why Investors Shouldn't Be Surprised By Nanjing Red Sun Co.,Ltd.'s (SZSE:000525) 25% Share Price Plunge

Improved Revenues Required Before Nanjing Red Sun Co.,Ltd. (SZSE:000525) Stock's 28% Jump Looks Justified

Mar 25
Improved Revenues Required Before Nanjing Red Sun Co.,Ltd. (SZSE:000525) Stock's 28% Jump Looks Justified

Ripartizione dei ricavi e delle spese

Come Nanjing Red SunLtd guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

SZSE:000525 Ricavi, spese e utili (CNY Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Sep 243,282-386541294
30 Jun 243,272-386526294
31 Mar 243,331-380527296
31 Dec 233,232-389532295
30 Sep 233,719-190518164
30 Jun 234,566133541225
31 Mar 235,659438556272
01 Jan 236,440732624285
30 Sep 227,023-2,835637304
30 Jun 226,195-3,157630239
31 Mar 225,351-3,461643205
01 Jan 224,683-3,744555168
30 Sep 214,090-213526147
30 Jun 213,989-190485142
31 Mar 214,147-139482134
31 Dec 204,022-154473142
30 Sep 203,476-535732126
30 Jun 204,044-524764124
31 Mar 204,117-453727114
31 Dec 194,614-340767108
30 Sep 195,75836858694
30 Jun 195,69650157998
31 Mar 195,728554628106
31 Dec 185,908637638109
30 Sep 185,665753613133
30 Jun 185,409749554159
31 Mar 185,261759584123
31 Dec 175,07271455096
30 Sep 174,11260947559
30 Jun 173,8064205150
31 Mar 173,9032564630
31 Dec 163,5381264520
30 Sep 163,39713890
30 Jun 163,418643820
31 Mar 164,0061293630
31 Dec 154,5571823600
30 Sep 156,0832494110
30 Jun 156,8193154030
31 Mar 156,7303804240
31 Dec 146,8124274140
30 Sep 147,3205063940
30 Jun 147,2594963930
31 Mar 147,2854343500
31 Dec 137,2413723290

Guadagni di qualità: 000525 is currently unprofitable.

Margine di profitto in crescita: 000525 is currently unprofitable.


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: 000525 is unprofitable, and losses have increased over the past 5 years at a rate of 1.4% per year.

Accelerare la crescita: Unable to compare 000525's earnings growth over the past year to its 5-year average as it is currently unprofitable

Guadagni vs Settore: 000525 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.8%).


Rendimento del capitale proprio

ROE elevato: 000525 has a negative Return on Equity (-37.04%), as it is currently unprofitable.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate